|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.34 USD | +1.41% |
|
+0.35% | -13.83% |
| 12-11 | Argus Downgrades Colgate-Palmolive to Hold From Buy | MT |
| 12-10 | Colgate-Palmolive Keeps Quarterly Dividend at $0.52 a Share, Payable Feb. 13, 2026, to Holders of Record Jan. 21 | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 15.3 | 15.47 | 14.64 | 15.34 | 16.38 | |||||
Return on Total Capital | 25.8 | 26.4 | 23.83 | 24.52 | 27.85 | |||||
Return On Equity % | 344.79 | 225.68 | 221.38 | 278.5 | 406.26 | |||||
Return on Common Equity | 626.74 | 320.41 | 353.47 | 455.45 | 703.78 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 60.84 | 59.55 | 57.04 | 58.22 | 60.6 | |||||
SG&A Margin | 37.01 | 37.18 | 36.87 | 37.19 | 38.85 | |||||
EBITDA Margin % | 26.28 | 25.18 | 23.09 | 23.17 | 24.15 | |||||
EBITA Margin % | 23.54 | 22.5 | 20.5 | 20.63 | 21.52 | |||||
EBIT Margin % | 23 | 21.99 | 20.06 | 20.26 | 21.14 | |||||
Income From Continuing Operations Margin % | 17.36 | 13.42 | 10.95 | 12.62 | 15.17 | |||||
Net Income Margin % | 16.36 | 12.43 | 9.93 | 11.82 | 14.37 | |||||
Net Avail. For Common Margin % | 16.36 | 12.43 | 9.93 | 11.82 | 14.37 | |||||
Normalized Net Income Margin | 12.8 | 12.17 | 11.03 | 11.18 | 11.79 | |||||
Levered Free Cash Flow Margin | 18.04 | 12.33 | 8.31 | 14.09 | 16.92 | |||||
Unlevered Free Cash Flow Margin | 18.73 | 13.02 | 8.89 | 15.02 | 17.83 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.06 | 1.13 | 1.17 | 1.21 | 1.24 | |||||
Fixed Assets Turnover | 3.88 | 4.1 | 3.97 | 3.95 | 4.01 | |||||
Receivables Turnover (Average Receivables) | 12.18 | 13.6 | 12.83 | 12.59 | 12.94 | |||||
Inventory Turnover (Average Inventory) | 4.2 | 4.19 | 4.1 | 4.06 | 4.04 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.99 | 1.09 | 1.28 | 1.11 | 0.92 | |||||
Quick Ratio | 0.5 | 0.54 | 0.61 | 0.58 | 0.48 | |||||
Operating Cash Flow to Current Liabilities | 0.84 | 0.82 | 0.64 | 0.79 | 0.71 | |||||
Days Sales Outstanding (Average Receivables) | 30.04 | 26.83 | 28.45 | 28.98 | 28.29 | |||||
Days Outstanding Inventory (Average Inventory) | 87.19 | 87.16 | 89.04 | 89.97 | 90.6 | |||||
Average Days Payable Outstanding | 71.59 | 74.19 | 68.26 | 74.21 | 80.4 | |||||
Cash Conversion Cycle (Average Days) | 45.64 | 39.8 | 49.23 | 44.74 | 38.48 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 746.05 | 808.86 | 1.15K | 947.13 | 1.56K | |||||
Total Debt / Total Capital | 88.18 | 89 | 92 | 90.45 | 93.99 | |||||
LT Debt/Equity | 709.36 | 789.5 | 1.13K | 902.72 | 1.42K | |||||
Long-Term Debt / Total Capital | 83.84 | 86.87 | 90.68 | 86.21 | 85.52 | |||||
Total Liabilities / Total Assets | 93.08 | 93.54 | 94.88 | 94.16 | 96.61 | |||||
EBIT / Interest Expense | 20.7 | 19.95 | 21.58 | 13.74 | 14.55 | |||||
EBITDA / Interest Expense | 24.62 | 23.72 | 25.8 | 16.26 | 17.19 | |||||
(EBITDA - Capex) / Interest Expense | 22.38 | 20.77 | 21.63 | 13.8 | 15.27 | |||||
Total Debt / EBITDA | 1.82 | 1.72 | 2.15 | 1.94 | 1.7 | |||||
Net Debt / EBITDA | 1.62 | 1.53 | 1.93 | 1.7 | 1.45 | |||||
Total Debt / (EBITDA - Capex) | 2.01 | 1.97 | 2.57 | 2.29 | 1.91 | |||||
Net Debt / (EBITDA - Capex) | 1.78 | 1.75 | 2.3 | 2 | 1.63 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.96 | 5.77 | 3.13 | 8.29 | 3.31 | |||||
Gross Profit, 1 Yr. Growth % | 7.34 | 3.53 | -1.22 | 10.53 | 7.54 | |||||
EBITDA, 1 Yr. Growth % | 5.64 | 1.36 | -5.21 | 9.26 | 7.67 | |||||
EBITA, 1 Yr. Growth % | 5.47 | 1.11 | -5.78 | 9.61 | 7.75 | |||||
EBIT, 1 Yr. Growth % | 4.84 | 1.11 | -5.68 | 10.05 | 7.81 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 13.18 | -18.25 | -15.87 | 24.81 | 24.2 | |||||
Net Income, 1 Yr. Growth % | 13.86 | -19.63 | -17.59 | 28.85 | 25.61 | |||||
Normalized Net Income, 1 Yr. Growth % | 4.69 | 0.59 | -8.27 | 10.45 | 8.97 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 14.18 | -18.79 | -16.47 | 30.05 | 26.71 | |||||
Accounts Receivable, 1 Yr. Growth % | -12.22 | 2.61 | 15.96 | 5.45 | -4.1 | |||||
Inventory, 1 Yr. Growth % | 19.5 | 1.14 | 22.58 | -6.75 | 2.74 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.35 | 0.47 | 12.4 | 6.02 | -2.4 | |||||
Total Assets, 1 Yr. Growth % | 5.89 | -5.53 | 4.59 | 4.21 | -2.12 | |||||
Tangible Book Value, 1 Yr. Growth % | -1.37 | -14.03 | -5.18 | -3.76 | 2.73 | |||||
Common Equity, 1 Yr. Growth % | 535.04 | -18.04 | -34.15 | 51.87 | -65.19 | |||||
Cash From Operations, 1 Yr. Growth % | 18.7 | -10.59 | -23.13 | 46.52 | 9.67 | |||||
Capital Expenditures, 1 Yr. Growth % | 22.39 | 38.29 | 22.75 | 1.29 | -20.43 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 33.71 | -27.68 | -31.79 | 85.37 | 24.04 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 31.74 | -26.47 | -29.38 | 84.48 | 22.67 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.34 | 2.29 | 3.91 | 2.69 | 3.66 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.94 | 5.36 | 4.44 | 5.68 | 5.77 | |||||
Gross Profit, 2 Yr. CAGR % | 4.02 | 5.42 | 1.15 | 4.49 | 9.02 | |||||
EBITDA, 2 Yr. CAGR % | 0.7 | 2.66 | -2.08 | 1.59 | 8.73 | |||||
EBITA, 2 Yr. CAGR % | 0.77 | 2.85 | -1.38 | 1.42 | 8.97 | |||||
EBIT, 2 Yr. CAGR % | 0.4 | 2.53 | -2.46 | 1.68 | 9.23 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 5.74 | -3.81 | -17.07 | 2.47 | 24.5 | |||||
Net Income, 2 Yr. CAGR % | 5.97 | -4.34 | -18.62 | 3.05 | 27.22 | |||||
Normalized Net Income, 2 Yr. CAGR % | -0 | 2.14 | -3.01 | 0.42 | 10.06 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 6.86 | -3.7 | -17.64 | 4.22 | 28.37 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.98 | -5.1 | 9.08 | 10.58 | 0.56 | |||||
Inventory, 2 Yr. CAGR % | 15.69 | 9.94 | 11.34 | 6.91 | -2.12 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.49 | 0.06 | 6.27 | 9.16 | 1.72 | |||||
Total Assets, 2 Yr. CAGR % | 14.42 | 0.02 | -0.6 | 4.4 | 1 | |||||
Tangible Book Value, 2 Yr. CAGR % | 18.31 | -7.91 | -9.71 | -4.47 | -0.57 | |||||
Common Equity, 2 Yr. CAGR % | 169.89 | 128.15 | -26.54 | 0 | -27.29 | |||||
Cash From Operations, 2 Yr. CAGR % | 10.32 | 3.02 | -17.1 | 6.13 | 26.76 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.03 | 30.1 | 30.29 | 11.51 | -10.22 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 11.85 | -2.85 | -29.1 | 12.06 | 52.28 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 11.19 | -2.71 | -28.03 | 13.77 | 51.03 | |||||
Dividend Per Share, 2 Yr. CAGR % | 2.68 | 2.31 | 3.1 | 3.3 | 3.18 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.15 | 3.87 | 4.61 | 5.71 | 4.89 | |||||
Gross Profit, 3 Yr. CAGR % | 2.32 | 3.86 | 3.16 | 4.18 | 5.49 | |||||
EBITDA, 3 Yr. CAGR % | -0.47 | 0.92 | -0.11 | 1.38 | 3.58 | |||||
EBITA, 3 Yr. CAGR % | -0.7 | 0.88 | -0.2 | 1.95 | 3.49 | |||||
EBIT, 3 Yr. CAGR % | -1.17 | 0.63 | -0.37 | 1.34 | 3.68 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 9.57 | -2.95 | -8.01 | -4.96 | 9.25 | |||||
Net Income, 3 Yr. CAGR % | 10.01 | -3.36 | -8.98 | -5.15 | 10.08 | |||||
Normalized Net Income, 3 Yr. CAGR % | -2.09 | 0.19 | -0.83 | 1.05 | 3.19 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 11.26 | -2.49 | -8.16 | -4.09 | 11.24 | |||||
Accounts Receivable, 3 Yr. CAGR % | -5.12 | -2.52 | 1.46 | 7.86 | 5.45 | |||||
Inventory, 3 Yr. CAGR % | 11.07 | 10.62 | 14 | 4.95 | 5.5 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.33 | 3.13 | 4.02 | 6.19 | 5.16 | |||||
Total Assets, 3 Yr. CAGR % | 7.89 | 7.34 | 1.52 | 0.98 | 2.18 | |||||
Tangible Book Value, 3 Yr. CAGR % | 18.19 | 6.36 | -7.01 | -7.77 | -2.13 | |||||
Common Equity, 3 Yr. CAGR % | 131.36 | 81.41 | 50.77 | -6.41 | -29.65 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.79 | 2.85 | -6.56 | 0.23 | 7.29 | |||||
Capital Expenditures, 3 Yr. CAGR % | -9.49 | 9.15 | 27.6 | 19.8 | -0.35 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 7.21 | -3.28 | -13.12 | -2.62 | 15.92 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 7.17 | -3.13 | -12.64 | -1.79 | 16.67 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.25 | 2.55 | 2.84 | 2.96 | 3.42 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.54 | 2.77 | 3.06 | 4.59 | 5.08 | |||||
Gross Profit, 5 Yr. CAGR % | 1.25 | 2.5 | 1.84 | 4.11 | 5.46 | |||||
EBITDA, 5 Yr. CAGR % | -0.21 | -0.1 | -1.12 | 1.1 | 3.12 | |||||
EBITA, 5 Yr. CAGR % | -0.51 | -0.44 | -1.43 | 1.01 | 3.14 | |||||
EBIT, 5 Yr. CAGR % | -0.8 | -0.74 | -1.69 | 0.96 | 3.12 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 1.68 | -2 | -1.98 | -0.82 | 3.83 | |||||
Net Income, 5 Yr. CAGR % | 14.26 | -2.36 | -2.48 | -0.85 | 4.07 | |||||
Normalized Net Income, 5 Yr. CAGR % | -1.64 | -1.47 | -2.47 | 0.62 | 3.11 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.98 | -1.28 | -1.35 | 0.14 | 5 | |||||
Accounts Receivable, 5 Yr. CAGR % | -2.4 | -1.67 | 0.32 | 2.53 | 1.1 | |||||
Inventory, 5 Yr. CAGR % | 7.23 | 7.64 | 11.18 | 9.12 | 7.25 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.22 | 2.08 | 3.28 | 5.5 | 3.09 | |||||
Total Assets, 5 Yr. CAGR % | 5.93 | 4.41 | 4.41 | 6.15 | 1.31 | |||||
Tangible Book Value, 5 Yr. CAGR % | 9.78 | 7 | 6.12 | 1.89 | -4.49 | |||||
Common Equity, 5 Yr. CAGR % | 19.97 | 20.17 | 46.22 | 42.96 | 12.62 | |||||
Cash From Operations, 5 Yr. CAGR % | 4.75 | 1.15 | -3.5 | 4.15 | 5.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | -9.91 | -0.89 | 4.71 | 10.09 | 10.86 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.67 | -4.95 | -9.13 | 2.92 | 8.36 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 5.7 | -4.55 | -8.61 | 3.21 | 8.38 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.13 | 2.92 | 3.19 | 2.85 | 2.98 |
- Stock Market
- Equities
- CL Stock
- Financials Colgate-Palmolive Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















